A phase I-II trial of BMS-275291 [rebimastat] in patients with HIV-related Kaposi's sarcoma
Phase of Trial: Phase I/II
Latest Information Update: 20 May 2009
At a glance
- Drugs Rebimastat (Primary)
- Indications Kaposi's sarcoma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 20 Sep 2007 Status change from in progress to completed.
- 04 Oct 2005 New trial record.